Bioject Medical Technologies Inc. Reports Second-Quarter 2008 Financial Results

August 6, 2008 |

1 min read

PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free drug delivery systems, today reported financial results for the second quarter ended June 30, 2008.

Earnings

MORE ON THIS TOPIC

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Series A

Novo-Backed Crystalys Debuts With $205M to Tackle Gout

September 30, 2025

·

2 min read

·

Tristan Manalac

Red Businesswoman Silhouette, Black Business People Group Team Concept Vector Illustration

Editorial

GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling

September 29, 2025

·

1 min read

·

Annalee Armstrong

GSK CEO Emma Walmsley

C-suite

GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years

September 29, 2025

·

4 min read

·

Annalee Armstrong

Biogen’s headquarters in Massachusetts

Layoffs

Biogen Shuffles 20 Staff After Ending AAV Work

September 29, 2025

·

2 min read

·

Tristan Manalac